BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15036666)

  • 41. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pak-1 expression increases with progression of colorectal carcinomas to metastasis.
    Carter JH; Douglass LE; Deddens JA; Colligan BM; Bhatt TR; Pemberton JO; Konicek S; Hom J; Marshall M; Graff JR
    Clin Cancer Res; 2004 May; 10(10):3448-56. PubMed ID: 15161701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
    Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer.
    Downs LS; Lima PH; Bliss RL; Blomquist CH
    J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
    Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
    Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
    Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
    Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
    Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
    Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endometrial carcinoma expresses an increased cathepsin B/D ratio.
    Bradley WH; Lima PH; Rodgers L; Blomquist CH; Downs LS
    Gynecol Oncol; 2008 Jan; 108(1):84-9. PubMed ID: 17980407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
    Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
    Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of phospholipase D2 in human colorectal carcinoma.
    Saito M; Iwadate M; Higashimoto M; Ono K; Takebayashi Y; Takenoshita S
    Oncol Rep; 2007 Nov; 18(5):1329-34. PubMed ID: 17914593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
    van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
    Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.